Stem Cell Versus Platelet-rich Plasma for Knee Osteoarthritis: A Systematic Review
DOI:
https://doi.org/10.3889/oamjms.2023.11516Keywords:
knee osteoarthritis, mesenchymal stem cells, outcome, platelet-rich plasmaAbstract
AIM: The objective is to compare the outcomes of intra-articular injection of mesenchymal stem cells (MSCs) to platelet-rich plasma (PRP) as a treatment modality for knee osteoarthritis (OA).
METHODS: Systematic review was conducted based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses and PICO criteria for the past 10 years of publications. Keywords used to search with Boolean operator: “knee OA” AND “MSCs” AND“PRP” AND “outcome.” All selected articles were assessed for their quality based on strengthening the Reporting of Observational Studies in Epidemiology checklist.
RESULTS: We selected five articles of prospective cohort studies, which involved 54 patients whom received combination therapies of MSCs+PRP, 206 patients received MSCs only treatment and 86 patients received PRP only treatment. It was shown that MSCs had superior outcomes compared to PRP treatment in terms of VAS and KOOS, where combinations of MSCs and PRP treatment had no significant difference compared to the MSCs treatment alone. Nonetheless, each treatment showed a significant improvement of KOOS, VAS, WOMAC, IKDC, knee, and function knee scores from their baselines.
CONCLUSION: Intra-articular injections are effective and safe for the management of knee OA. MSCs treatment has superior effect on the treatment outcomes compared to PRP treatment. Combination of both treatments is comparable to MSCs treatment alone.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
CDC. Osteoarthritis. CDC; 2022. Available from: https://www. cdc.gov/arthritis/types/osteoarthritis.htm [Last accessed on 2022 Jun 14].
Kolasinski SL, Neogi MC, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rhematol. 2020;72(2):220-33.
Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355-69. https://doi.org/10.1016/j. cger.2010.03.001. Erratum in: Clin Geriatr Med. 2013;29(2):ix. PMid:20699159
Estrada E, Décima J, Rodríguez M, Di Tomaso M, Roberti J. Patient-reported outcomes after platelet-rich plasma, bone marrow aspirate, and adipose-derived mesenchymal stem cell injections for symptomatic knee osteoarthritis. Clin Med Insights Arthritis Musculoskelet Disord. 2020;13:117954412093108. https://doi.org/10.1177/1179544120931086 PMid:32669883
Fibel KH, Hillstrom HJ, Halpern BC. State-of-the-art management of knee osteoarthritis. World J Clin Cases. 2015;3(2):89-101. https://doi.org/10.12998/wjcc.v3.i2.89 PMid:25685755
Lamo-Espinosa J, Blanco J, Sánchez M, Moreno V, Granero- Moltó F, Sánchez-Guijo F, et al. Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis. J Transl Med. 2020;18(1):356. https://doi.org/10.1186/s12967-020-02530-6 PMid:32948200
Bennell KL, Hunter DJ, Paterson KL. Platelet-rich plasma for the management of hip and knee osteoarthritis. Curr Rheumatol Rep. 2017;19(5):24. https://doi.org/10.1007/s11926-017-0652-x PMid:28386761
Andia I, Maffulli N. New biotechnologies for musculoskeletal injuries. Surgeon. 2019;17(4):244-255. https://doi.org/10.1016/j.surge.2018.08.004 PMid:30170915
Murphy JM, Fink DJ, Hunziker EB, Barry FP. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003;48(12):3464-74. https://doi.org/10.1002/art.11365 PMid:14673997
Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Efects of dexa-methasone and IL-1 alpha. J Cell Physiol. 1996;166(3):585-92. https://doi.org/10.1002/ (SICI)1097-4652(199603)166:33.0.CO;2-6 PMid:8600162
Brittberg M, Lindahl A, Nilsson A, Ohlsson C, n L. Treatment of deep cartilage defects n the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331(14):889-95. https://doi.org/10.1056/NEJM199410063311401 PMid:8078550
Knutsen G, Drogset JO, Engebretsen L, Grøntvedt T, Isaksen V, Ludvigsen TC, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007;89(10):2105-12. https://doi.org/10.2106/JBJS.G.00003 PMid:17908884
Grassel S, Ahmed N. Influence of cellular microenvironment and paracrine signals on chondrogenic differentiation. Front Biosci. 2007;12:4946-56. https://doi.org/10.2741/2440 PMid:17569622
Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ. Comparison of effect of BMP-2,-4, and-6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res. 2005;320(2):269-76. https://doi.org/10.1007/s00441-004-1075-3 PMid:15778851
Paoloni J, De Vos RJ, Hamilton B, Murrell GA, Orchard J. Platelet-rich plasma treatment for ligament and tendon injuries. Clin J Sport Med. 2011;21(1):37-45. https://doi.org/10.1097/JSM.0b013e31820758c7 PMid:2120016
Koh YG, Kwon OR, Kim YS, Choi YJ. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: A prospective study. Arthroscopy. 2014;30(11):1453-60. https://doi.org/10.1016/j.arthro.2014.05.036 PMid:25108907
Bastos R, Mathias M, Andrade R, Bastos R, Balduino A, Schott V, et al. Intra-articular injections of expanded mesenchymal stem cells with and without addition of platelet-rich plasma are safe and effective for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2018;26(11):3342-50. https://doi.org/10.1007/s00167-018-4883-9 PMid:29511819
Dulic O, Rasovic P, Lalic I, Kecojevic V, Gavrilovic G, Abazovic D, et al. Bone marrow aspirate concentrate versus platelet rich plasma or hyaluronic acid for the treatment of knee osteoarthritis. Medicina (Kaunas). 2021;57(11):1193. https://doi.org/10.3390/medicina57111193 PMid: 34833411
Bastos R, Mathias M, Andrade R, Amaral R, Schott V, Balduino A, et al. Intra-articular injection of culture-expanded mesenchymal stem cells with or without addition of platelet-rich plasma is effective in decreasing pain and symptoms in knee osteoarthritis: A controlled, double-blind clinical trial. Knee Surg Sports Traumatol Arthrosc. 2019;28(6):1989-99. https://doi.org/10.1007/s00167-019-05732-8 PMid:31587091
Venosa M, Calafiore F, Mazzoleni M, Romanini E, Cerciello S, Calvisi V. Platelet-rich plasma and adipose-derived mesenchymal stem cells in association with arthroscopic microfracture of knee articular cartilage defects: A pilot randomized controlled trial. Adv Orthop. 2022;2022:6048477. https://doi.org/10.1155/2022/6048477 PMid:35529427
Baria M, Pedroza A, Kaeding C, Durgam S, Duerr R, Flanigan D, et al. Platelet-rich plasma versus microfragmented adipose tissue for knee osteoarthritis: A randomized controlled trial. Orthopaedic J Sports Med. 2022;10(9):23259671221120678. https://doi.org/10.1177/23259671221120678 PMid:36147791
Kon E, Di Matteo B, Delgado D, Cole BJ, Dorotei A, Dragoo JL, et al. Platelet-rich plasma for the treatment of knee osteoarthritis: An expert opinion and proposal for a novel classification and coding system. Expert Opin Biol Ther. 2020;20(12):1447-60. https://doi.org/10.1080/14712598.2020.1798925 PMid:32692595
Cao Z, Li Y, Gao F, Wu R, Dou P, Wang W, et al. Mesenchymal stem cells: A new choice for nonsurgical treatment of OA? Results from a Bayesian network meta-analysis. Biomed Res Int. 2021;2021:6663003. https://doi.org/10.1155/2021/6663003 PMid:33614784
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 I Wayan Suryanto Dusak, Agus Eka Wiradiputra, Gusti Ngurah Paramartha Wijaya Putra, I Gde Made Satya Wangsa (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
